Sulfinpyrazone

In the US, Sulfinpyrazone (sulfinpyrazone systemic) is a member of the drug class antigout agents and is used to treat Gouty Arthritis.

US matches:

• Sulfinpyrazone

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

M04AB02

CAS registry number (Chemical Abstracts Service)

0000057-96-5

Chemical Formula

C23-H20-N2-O3-S

Molecular Weight

404

Therapeutic Category

Uricosuric agent

Chemical Name

3,5-Pyrazolidinedione, 1,2-diphenyl-4-[2-(phenylsulfinyl)ethyl]-

Foreign Names

• Sulfinpyrazonum (Latin)
• Sulfinpyrazon (German)
• Sulfinpyrazone (French)
• Sulfinpirazona (Spanish)

Generic Names

• Sulfinpirazone (OS: DCIT)
• Sulfinpyrazone (OS: JAN, DCF, BAN)
• G 28315 (IS)
• Sulphinpyrazone (IS)
• Sulfinpyrazon (PH: Ph. Eur. 6)
• Sulfinpyrazone (PH: BP 2010, JP XIV, USP 32, Ph. Eur. 6)
• Sulfinpyrazonum (PH: Ph. Eur. 6)

Brand Names

• Anturan
  Amdipharm, United Kingdom; Cisuba, Sudan; Heko, Tanzania; Lindsay-Chemie, Zimbabwe; Medview, Ghana; Novartis, Guyana; Novartis, Israel; Novartis, Kenya; Novartis, Libya; Novartis, Nigeria



• Anturane
  Novartis, United States



• Apo-Sulfinpyrazone
  Apotex, Canada



• Enturen
  Medivis, Italy



• Sulfin
  TTY Biopharm, Taiwan

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.